Edition:
United States

Lisa Girion

U.S. congressional panel to probe court secrecy

Sep 09 2019

SAN FRANCISCO A U.S. House of Representatives subcommittee will hear testimony this month about a lack of transparency in the federal courts, with a focus on judges who routinely keep important evidence secret at the public's expense.

Special Report: How judges added to the grim toll of opioids

Jun 25 2019

By Benjamin Lesser, Dan Levine, Lisa Girion and Jaimi Dowdell

Special Report: As Baby Powder concerns mounted, J&J focused marketing on minority, overweight women

Apr 09 2019

LOS ANGELES Pressure was mounting on Johnson & Johnson and its signature Baby Powder.

Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documents

Apr 08 2019

A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for common aches and pains in the United States has agreed to testify against the OxyContin maker and other drug companies, newly disclosed court records show.

After damaging Reuters report, J&J doubles down on talc safety message

Dec 31 2018

NEW YORK/LOS ANGELES Johnson & Johnson Inc's statement was unequivocal.

Johnson & Johnson kept a guiding hand on talc safety research

Dec 15 2018

LOS ANGELES Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

Special Report: J&J knew for decades that asbestos lurked in its Baby Powder

Dec 14 2018

LOS ANGELES Darlene Coker knew she was dying. She just wanted to know why.

J&J kept a guiding hand on talc safety research

Dec 14 2018

LOS ANGELES Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

J&J kept a guiding hand on talc safety research

Dec 14 2018

LOS ANGELES, Dec 14 Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

World News